Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Global News Feed
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
Posted: March 8, 2025 at 2:45 am
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th Annual Global Healthcare Conference, which will be held in Miami, Florida on March 11-13, 2025. Robert Wessman, founder, chairman and CEO and members of the management team will host one-on-one meetings. Alvotech will also be participating in a fireside chat on Wednesday, March 12, 2025, at 9:30-9:55 am EDT (13:30-13:55 GMT).
Posted in Global News Feed
Comments Off on Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
Posted: March 8, 2025 at 2:45 am
SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that Capricor management will participate in one-on-one investor meetings and provide a corporate update at Leerink’s Global Healthcare Conference 2025, taking place March 10-12, 2025 in Miami, Florida.
More here:
Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
Posted in Global News Feed
Comments Off on Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting
Posted: March 8, 2025 at 2:45 am
Basel, March 7, 2025 – Novartis shareholders today agreed to the Board of Directors’ recommendations for all proposed resolutions at the company’s Annual General Meeting (AGM). A total of 1,693 shareholders were present at the meeting held in Basel, representing approximately 57.42% of the issued shares of Novartis.
Read the original:
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting
Posted in Global News Feed
Comments Off on Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion…
Posted: March 8, 2025 at 2:45 am
Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments
Posted in Global News Feed
Comments Off on Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion…
NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive…
Posted: March 8, 2025 at 2:45 am
BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) and its completion of its acquisition of MicroSort Reproductive Technology.
Posted in Global News Feed
Comments Off on NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive…
Virbac : Declaration of the number of shares and voting rights 02/25
Posted: March 8, 2025 at 2:45 am
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS
Original post:
Virbac : Declaration of the number of shares and voting rights 02/25
Posted in Global News Feed
Comments Off on Virbac : Declaration of the number of shares and voting rights 02/25
Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting
Posted: March 8, 2025 at 2:45 am
Nck modulator reduced evidence of inflammation in an animal model of dermal irritation
View original post here:
Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting
Posted in Global News Feed
Comments Off on Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted: March 8, 2025 at 2:45 am
BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired employee. The awards were made as inducements material to the individual’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
Continued here:
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted in Global News Feed
Comments Off on Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
Posted: March 8, 2025 at 2:45 am
Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the closing of its initial public offering (the "Offering") of 1,640,000 shares of common stock (the “Shares”), at a public offering price of $4.00 per share for total gross proceeds of $6.56 million before deducting underwriting discounts and offering expenses. The Shares began trading on the Nasdaq Capital Market on March 6, 2025 under the ticker symbol “ADVB.”
Read the original here:
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
Posted in Global News Feed
Comments Off on Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
Tsay Keh Dene Nation partners with Tersa Earth to drive sustainable mining solutions
Posted: March 8, 2025 at 2:45 am
BURNABY, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- The Tsay Keh Dene Nation (TKDN) and Tersa Earth Innovations Inc. are pleased to announce a strategic investment and partnership focused on the future of Tersa Earth’s cleantech mining platform.
More here:
Tsay Keh Dene Nation partners with Tersa Earth to drive sustainable mining solutions
Posted in Global News Feed
Comments Off on Tsay Keh Dene Nation partners with Tersa Earth to drive sustainable mining solutions
